🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Opening Ceremony PCRonline 🫀 #EuroPCR 2025 A.Nazmi Calik Arif Khokhar MIЯVΛƬ #IC Aaysha Cader Erik Rafflenbeul Alessandro Sticchi DrThomasCuisset

Looking forward to presenting invasive LV & RV pressure-volume loop data comparing the impact of MR reduction Vs elimination in #TEER 💫 Should MR elimination always be the goal⁉️ Promises to be an interesting session chaired by 🌟 experts João Cavalcante A.Duncan #EuroPCR

Valve-in-valve TAVR is safe and effective for small aortic annuli. A report from a Japanese Nationwide Registry presented PCRonline 🫀 #EuroPCR and published simultaneously Yohei Turi Ohno EuroIntervention #AHAJournals #cardiotwitter ahajrnls.org/45lfFCd

Incidence, evolution and impact of cardiac damage in asymptomatic patients with severe #vhdAS ❤️‍🩹 Interesting analysis of the EARLY TAVR trial by Philippe Genereux #EuroPCR 2025 🇫🇷 Should we redefine the definition of severe #vhdAS?

📢 Just released at #EuroPCR: New analysis from the #PROTECTED and #BHFPROTECT-TAVI trials on the use of #Sentinel during #TAVI. 🔹 No significant reduction ⬇️ in periprocedural stroke when used routinely 🔹 However, per-protocol analysis shows a #significant benefit of Sentinel

🔥#EuroPCR 2025 Major Late-Breaking Trials results: Angiography versus physiology-guided PCI in patients undergoing TAVI FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,

In another study published in #JACCINT, the timing of noncardiac surgery after #TAVR was not associated with increased perioperative risk, suggesting that surgical delays based solely on interval from TAVR may be unnecessary. jacc.org/doi/10.1016/j.… #vhdAS #cvSurg

Non-coaxial transcatheter aortic valve deployment relative to the native annulus is associated with impaired valve early safety and increased risk of bioprosthetic valve failure 1 year after TAVR. jacc.org/doi/10.1016/j.…

British Heart Foundation funds more than 50% of cardiovascular research in the UK, leading to major advances in the fight against heart and circulatory disease. I will be cycling approximately 100km #L2B2025 on 15th June to raise funds for this amazing charity. justgiving.com/team/cardiaccy…

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx tctmd.com/news/pressure-… Ozan M. Demir Divaka Perera British Heart Foundation Cardiovascular and Metabolic Medicine & Sciences TCTMD Caitlin E. Cox CircInterventions William Fearon

📰tctmd.com/news/pressure-… 🔗ahajournals.org/doi/full/10.11… ⁉️ Should diagnostic thresholds for FFR, iFR, CFR be specific to each vessel. TCTMD Caitlin E. Cox CircInterventions Sunil V. Rao William Fearon Mamas A. Mamas Gregg W. Stone MD John Mandrola, MD curzen Rasha Al-Lamee Dr Shrilla Banerjee MD FRCP 💙 Giuseppe Biondi-Zoccai Javier Escaned

Our publication in EHJ: In ILUMIEN IV, >50% of lesions were mod/sev calcified. OCT-guided PCI in calcified lesions reduced 2-yr rate of TVF and serious MACE - one of the best uses for OCT guidance! Free access link: academic.oup.com/eurheartj/adva…

How fast can you get your Aortic Stenosis patient thru the system.? Time matters in TAVI candidates with decompensated aortic stenosis #AHAJournals Michael McKenna Thomas Treibel Guy Lloyd Sanjeev Bhattacharyya Michael Mullen ahajrnls.org/3ZRLsXS

This study showed that the SAPIEN 3 Ultra RESILIA (S3UR) valve offers significantly better performance for #TAVR in severe aortic stenosis compared to the SAPIEN 3 valve. The S3UR valve reduces paravalvular leakage (PVL) and patient-prosthesis mismatch (PPM), especially in

Acetylcholine provocation testing. How does dosing affect the diagnostic performance in the detection of coronary spasm in ANOCA? Rajan Rehan #Cardiotwitter #AHAJournals ahajrnls.org/44ALvKs

Great cases and presentations from the Montefiore Heart team. Edwin Ho Andrea Scotti Pier Pasquale Leone Ulrich Jorde Manaf Assafin Montefiore Health System

In severe AS women with no CAD fare worse then men. Sex differences in CAD impact after AS treatment. A Report from the PARTNER trials Vanderbilt Structural Heart & Valve Center Philippe Pibarot RTHahnMD Sammy Elmariah MD MPH Maria Alu Labo Dr Clavel Omar Khalique #AHAJournals ahajrnls.org/447lgvc

A clear and concise lay summary by British Heart Foundation on the impact of the LMCA Physiology study👏 🔗Manuscript: ahajournals.org/doi/10.1161/CI… - CircInterventions Sunil V. Rao 🔗Editorial: ahajournals.org/doi/10.1161/CI… - William Fearon 🔗BHF 📰: bhf.org.uk/what-we-do/new… King's Faculty of Life Sciences & Medicine Cardiovascular and Metabolic Medicine & Sciences King's BHF Centre

🔑 We recommend using adenosine, dobutamine & ACh for full MB phenotyping in the cath lab 🔑 bit.ly/3TnnY9y Javier Escaned Viviany Taqueti Carlos Collet MD PhD Ritu Thamman MD Professor Vijay Kunadian William Fearon Habib Samady Janet Wei MD samitshahmd Michel T. Corban, MD Rajiv Gulati Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Great work Matthew Li Kam Wa and the SERIAL Trial group! 1️⃣ pre-PCI #pullback is essential (can change treatment strategy and target lesion) 2️⃣ BUT we tend to overestimate the effect of PCI/underestimate impact of non-target disease by FFR or iFR 3️⃣ must check post-PCI FFR+pullback